| E-Y0000413 |
EP |
【磺胺甲惡唑雜質F（ |
Sulfamethoxazole impurity F |
|
5 mg |
1264 |
28 |
| E-Y0000414 |
EP |
【泰妙菌素峰值鑒別 |
Tiamulin for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0000415 |
EP |
【苯賴加壓素（訂貨以 |
Felypressin |
|
0.994 mg |
1484.59 |
42 |
| E-Y0000416 |
EP |
【雷尼替丁雜質J（訂 |
Ranitidine impurity J |
|
0.00025 mg |
1484.59 |
42 |
| E-Y0000417 |
EP |
【噴他佐辛乳酸參考 |
Pentazocine lactate - reference spectrum |
|
n/a |
1264 |
28 |
| E-Y0000418 |
EP |
【甲紫溶液（訂貨以英 |
Methylrosanilinium chloride |
|
40 mg |
1264 |
28 |
| E-Y0000419 |
EP |
【磷酸氟達拉濱（訂貨 |
Fludarabine phosphate |
|
120 mg |
1264 |
28 |
| E-Y0000420 |
EP |
【頭孢噻肟酸（訂貨以 |
Cefotaxime acid |
|
20 mg |
1264 |
28 |
| E-Y0000421 |
EP |
【司他夫定系統(tǒng)適應 |
Stavudine for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0000422 |
EP |
【沙美特羅（訂貨以英 |
Salmeterol xinafoate |
|
70 mg |
1264 |
28 |
| E-Y0000423 |
EP |
【沙美特羅系統(tǒng)適應 |
Salmeterol xinafoate for system suitability |
|
25 mg |
1264 |
28 |
| E-Y0000424 |
EP |
【苯磺酸阿曲庫銨 （ |
Atracurium besilate |
|
120 mg |
1484.59 |
42 |
| E-Y0000425 |
EP |
【拉米夫定（訂貨以英 |
Lamivudine |
|
150 mg |
1264 |
28 |
| E-Y0000426 |
EP |
【拉米夫定治療系統(tǒng) |
Lamivudine for system suitability 2 |
|
10.3 mg |
1264 |
28 |
| E-Y0000427 |
EP |
【阿卡波糖峰值鑒別 |
Acarbose for peak identification |
|
20 mg |
1264 |
28 |
粵公網安備 44010302000979號
